US 8492378
GSK-3β inhibitor
granted A61PA61P1/04A61P1/16
Quick answer
US patent 8492378 (GSK-3β inhibitor) held by Takeda Pharmaceutical Company Limited expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P11/00, A61P11/06